{"id":3537,"date":"2023-03-21T12:19:38","date_gmt":"2023-03-21T01:19:38","guid":{"rendered":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/problematic-psychedelics-prescribing-harm-researchers-warn-of-major-threats-to-the-validity-of-psychedelic-research-2\/"},"modified":"2023-03-21T12:19:38","modified_gmt":"2023-03-21T01:19:38","slug":"problematic-psychedelics-prescribing-harm-researchers-warn-of-major-threats-to-the-validity-of-psychedelic-research-2","status":"publish","type":"post","link":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/problematic-psychedelics-prescribing-harm-researchers-warn-of-major-threats-to-the-validity-of-psychedelic-research-2\/","title":{"rendered":"Problematic Psychedelics \u2013 Prescribing Harm? Researchers Warn of Major Threats to the Validity of Psychedelic Research"},"content":{"rendered":"<p><span style=\"color: #333333;\"><i>Warning of \u201chistory repeating,\u201d researchers list ten problems with psychedelic research that make conclusions about efficacy and safety uncertain.<\/i><br \/>March 20, 2023<\/span><\/p>\n<p><span style=\"color: #333333;\"><br \/>Drugs like ketamine, psilocybin (mushrooms), LSD, and MDMA are at the forefront of a new wave of&nbsp;<a href=\"https:\/\/www.technologyreview.com\/2022\/12\/16\/1065235\/mind-altering-substances-overhyped\/\" target=\"_blank\" rel=\"noopener\">overhyped<\/a>&nbsp;treatments for mental health problems that may fail to deliver on their promises, according to a new article by researchers Michael van Elk and Eiko Fried at Leiden University, the Netherlands. They write that psychedelic research is plagued by methodological problems that make the efficacy and safety of these drugs uncertain.<\/span><\/p>\n<p><span style=\"color: #333333;\"><br \/>Despite the minimal research and its limitations, the drugs have been&nbsp;<a href=\"https:\/\/www.madinamerica.com\/2021\/09\/psychedelics-new-psychiatric-craze\/\" target=\"_blank\" rel=\"noopener\">hyped<\/a>&nbsp;as&nbsp;<a href=\"https:\/\/www.rollingstone.com\/culture\/culture-features\/the-psychedelic-miracle-128798\/\" target=\"_blank\" rel=\"noopener\">\u201cmiracle\u201d drugs<\/a>, with some, like esketamine, even receiving FDA approval\u2014despite&nbsp;<a href=\"https:\/\/www.madinamerica.com\/2021\/11\/esketamine-failed-five-six-efficacy-trials\/\" target=\"_blank\" rel=\"noopener\">failing to beat placebo in five of its six initial efficacy trials<\/a>&nbsp;(the sixth trial reached statistical, but not clinical, significance). In fact, last year, researchers wrote that the promotion of ketamine\/esketamine treatments poses&nbsp;<a href=\"https:\/\/www.madinamerica.com\/2022\/11\/ketamine-significant-risk\/\" target=\"_blank\" rel=\"noopener\">\u201ca significant risk to the public.\u201d<\/a><br \/>In their new article, published before peer review on the preprint server PsyArXiv, van Elk and Fried focus on the top 10 methodological problems rampant in psychedelic research, how these issues undermine the evidence base, and how researchers can avoid them in the future.<\/span><\/p>\n<p><span style=\"color: #333333;\"><br \/><b>\u201cThese problems threaten internal validity (treatment effects are due to factors unrelated to the treatment), external validity (lack of generalizability), construct validity (an unclear working mechanism), or statistical conclusion validity (conclusions do not follow from the data and methods),\u201d the researchers write.<\/b><\/span><\/p>\n<p><span style=\"color: #333333;\"><br \/>Worse, they add, most psychedelic studies feature more than one of these problems, which makes the studies far more unreliable: \u201cThese problems tend to co-occur in psychedelic studies, strongly limiting conclusions that can be drawn about the safety and efficacy of psychedelic therapy.\u201d<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #333333;\"><a href=\"https:\/\/www.madinamerica.com\/2023\/03\/researchers-warn-of-major-threats-to-the-validity-of-psychedelic-research\/\" target=\"_blank\" rel=\"noopener\" class=\"button\">For complete article<\/a><\/span><\/p>\n<p><span style=\"color: #333333;\"><br \/>Also see&nbsp;<a href=\"https:\/\/nobrainer.org.au\/index.php\/student-teacher\/get-a-clue-partae\/986-lobbying-for-medicine-around-we-go-again-this-time-its-psychedelics\" target=\"_blank\" rel=\"noopener\">LOBBYING FOR MEDICINE \u2013 AROUND WE GO AGAIN (THIS TIME IT\u2019S PSYCHEDELICS)<\/a><br \/><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Warning of \u201chistory repeating,\u201d researchers list ten problems with psychedelic research that make conclusions about efficacy and safety uncertain.March 20, 2023 Drugs like ketamine, psilocybin (mushrooms), LSD, and MDMA are at the forefront of a new wave of&nbsp;overhyped&nbsp;treatments for mental health problems that may fail to deliver on their promises, according to a new article [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":"","_wp_rev_ctl_limit":""},"categories":[49],"tags":[],"class_list":["post-3537","post","type-post","status-publish","format-standard","hentry","category-drug-info-sheets"],"_links":{"self":[{"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/posts\/3537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/comments?post=3537"}],"version-history":[{"count":0,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/posts\/3537\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/media?parent=3537"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/categories?post=3537"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/tags?post=3537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}